Jun 22, 2021

Real Endpoints Marketplace for addressing high cost orphan medical benefit drugs is included in MIT’s white paper on emerging market solutions to address coverage and reimbursement challenges faced by durable cell and gene therapies.

Jun 22, 2021

Thoughts on Aduhelm’s approval from RE’s LinkedIn followers

Last week’s FDA approval of Aduhelm put the debate about sustainable, affordable access to innovation front and center. We surveyed

Jun 22, 2021

An important piece from the inaugural Chief Health Equity Officer at Humana, Nwando Olayiwola, M. D.

An important piece from the inaugural Chief Health Equity Officer at Humana, Nwando Olayiwola, M. D., on the need for health

Jun 22, 2021

Real Endpoints CEO, Jeff Berkowitz’s advice for those transitioning to an adjacent industry

Jun 22, 2021

Mental Health Month: The Expanding Role of Retail Pharmacy Providers

May is #MentalHealthMonth Great piece in New York Times highlighting the expanding role that retail pharmacy providers will play in providing

Jun 22, 2021

Dodging the Sword: The Cost-Saving Opportunity in Biologicals

The pharmaceutical industry faces a large and ugly problem: the growing economic burden on their payer customers of specialty drugs.